| Filed | Form | Filer | Stake | Shares | Intent | |
|---|---|---|---|---|---|---|
| 2026-11-06 | SCHEDULE 13D | ORBIMED ADVISORS LLC | 12.30% | 3,589,132 | view → | |
| 2026-11-06 | SCHEDULE 13G | FMR LLC | — | — | view → | |
| 2026-11-06 | SCHEDULE 13G | GILEAD SCIENCES, INC. | — | — | view → | |
| 2026-11-03 | SCHEDULE 13G | Qatar Investment Authority | — | — | view → |
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | Buy | 66,666 | $15.00 | $1000K |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 187,182 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 298,258 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 286,304 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 295,490 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 259,948 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | Buy | 66,667 | $15.00 | $1.00M |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | C | 214,355 | — | — |
| 2026-11-02 | ARCH Venture Fund X, L.P. | 10%+ | Buy | 1,200,000 | $15.00 | $18.00M |
| 2026-11-02 | ARCH Venture Partners XIV, L.P. | 10%+ | Buy | 1,200,000 | $15.00 | $18.00M |
| 2026-11-02 | Spaventa Andrew | director | C | 70,194 | — | — |
| 2026-11-02 | Spaventa Andrew | director | C | 180,221 | — | — |
| 2026-11-02 | Hasnain Faheem | director, officer | C | 14,913 | — | — |
| 2026-11-02 | Hasnain Faheem | director, officer | C | 14,316 | — | — |
| 2026-11-02 | Hasnain Faheem | director, officer | C | 7,120 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | C | 196,541 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | C | 642,745 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | C | 616,984 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | C | 625,743 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | C | 507,119 | — | — |
| 2026-11-02 | Thompson Peter A. | director, 10%+ | Buy | 1,000,000 | $15.00 | $15.00M |
| 2026-11-02 | ORBIMED ADVISORS LLC | director, 10%+ | C | 196,541 | — | — |
| 2026-11-02 | ORBIMED ADVISORS LLC | director, 10%+ | C | 642,745 | — | — |
| 2026-11-02 | ORBIMED ADVISORS LLC | director, 10%+ | C | 616,984 | — | — |
| 2026-11-02 | ORBIMED ADVISORS LLC | director, 10%+ | C | 625,743 | — | — |
Free. We email you when criteria match. One-click unsubscribe in every email.
Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.
See pricing →